NEW YORK (GenomeWeb News) – Paul Billings, the chief medical officer at Life Technologies, has been appointed to the US Food and Drug Administration's science board. Billings has previously served as the director and chief scientific officer at the Genomic Medicine Institute at El Camino Hospital, CEO at Cellective Dx, and the senior vice president for corporate development at the Laboratory Corporation of America.
Life sciences supply chain management company Marken has appointed Christopher O'Connell to be its new chief financial officer. O'Connell formerly was VP of finance for Thermo Fisher Scientific's Customer Channels Group, and while at Thermo Fisher he was involved in acquisitions, services management, and handling income statement responsibilities across multiple businesses.
Horizon Discovery has named Kam Dhaliwal to be its director of business development. Dhaliwal recently was VP of business development at Evotec, where he was responsible for growing the firm's businesses in Belgium, the Netherlands, Scandinavia, Spain, and the UK. He also formerly was head of European commercial development for Acumen Bioscience.
Exagen Diagnostics has hired Eric Tornoe to take over the post of company president and COO. Tornoe formerly worked at Pfizer, Wyeth, and Bristol-Myers Squibb.
Former National Institutes of Health Director Bernadine Healy has died, NIH said this week. Healy took the director job in 1991, and during her tenure she recruited current NIH Director Francis Collins to come to the institute to lead its International Human Genome Project, and was "a powerful advocate" for The Cancer Genome Atlas project, Collins said this week.
Benitec said that CFO John Rawling will resign on Aug. 24 and will be replaced by Greg West. The company said that Rawling's departure is related to the company's relocation to Sydney from Melbourne, Australia.
ThermoGenesis has named Robin Stracey to its board of directors, replacing Mahendra Rao who has resigned in order to take a position at the National Institutes of Health. Stracey is the president and CEO of Cantimer. Previously he was CEO of Applied Imaging, a medical devices company that is now a part of Danaher, and he also was vice president and general manager of chromatography and mass spectrometry at Thermo Fisher Scientific.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.